$ 25 million investment to VC fund, Integra Holdings, who is bringing the Hebrew U’s Life Science Academic Excellence to market, led by Temasek (SIngapore)
September 27th, 2017 – Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, today announced the first closing
Korea Investment Partners to finance Jlm-based Enlivex Therapeutics’s lead compound for the prevention of Graft Vs Host Disease (GVHD)
Sept 20, 2017 – Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, announced today the closing of an $8 million equity financing round at a valuation of approximately $50
Rosetrees Trust Interdisciplinary Prize awarded to Hebrew U scientists Yaakov Nahmias and Nir Friedman
Sept 18, 2017 – The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University of Jerusalem, Prof. Yaakov Nahmias
JLM-based BreathVision’s Breath Volume Monitoring keeps Patients Safe in the Operating Room
Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with the anesthetic. Rather, “drug-induced respiratory depression
Medtronic to open development centers in Jerusalem & Yokneam in cooperation with the Israel Innovation Authority
Sept 11, 2017 – Medical equipment company Medtronic will be the first company to establish development centers in Israel in cooperation with the Israel Innovation
Iowa Economic Mission Meets Jerusalem Biotech Leaders
Jerusalem, Israel – Sept. 11, 2017 – The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met with representatives of Jerusalem’s bio-medical
JLM based Entera Bio Raising $10m at $94m Valuation
Sept 13, 2017 – Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for a Nasdaq IPO, as well
BiondVax to Manufacture its Universal Flu Vaccine in Jerusalem!
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu vaccine. BiondVax Pharmaceuticals Ltd. also announced in
CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration
If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to join our clinical trial using
